Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huberman

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Neuropharmacology|September 29, 2001
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopaJ M Rabey, I Sagi, M Huberman, et al.
Annals of Internal Medicine|March 15, 1990
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trialM M Bern, J J Lokich, S R Wallach, et al.
Cellular Immunology|June 17, 1998
The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c miceH Rosenblatt-Bin, Y Kalechman, A Vonsover, et al.
Human Pathology|January 1, 1996
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritisH M el-Zimaity, D Y Graham, M T al-Assi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2018
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertionsZ Piotrowska, D B Costa, G R Oxnard, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Trials of 9-amino-20(S)-camptothecin in BostonJ P Eder, E Rubin, R Stone, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 8, 2011
High prevalence of malignant melanoma in Israeli patients with Parkinson's diseaseR Inzelberg, J M Rabey, E Melamed, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Neuropharmacology|September 29, 2001
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopaJ M Rabey, I Sagi, M Huberman, et al.
Annals of Internal Medicine|March 15, 1990
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trialM M Bern, J J Lokich, S R Wallach, et al.
Cellular Immunology|June 17, 1998
The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c miceH Rosenblatt-Bin, Y Kalechman, A Vonsover, et al.
Human Pathology|January 1, 1996
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritisH M el-Zimaity, D Y Graham, M T al-Assi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2018
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertionsZ Piotrowska, D B Costa, G R Oxnard, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Trials of 9-amino-20(S)-camptothecin in BostonJ P Eder, E Rubin, R Stone, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 8, 2011
High prevalence of malignant melanoma in Israeli patients with Parkinson's diseaseR Inzelberg, J M Rabey, E Melamed, et al.
Pageof 6